BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35261135)

  • 1. Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?
    Megna M; Potestio L; Di Caprio N; Tajani A; Fabbrocini G; Annunziata A
    Dermatol Ther; 2022 May; 35(5):e15423. PubMed ID: 35261135
    [No Abstract]   [Full Text] [Related]  

  • 2. Spesolimab Response in a Girl With Acrodermatitis Continua of Hallopeau.
    Wang Y; Zhang L; Zheng J; Li X; Chen L
    JAMA Dermatol; 2024 Apr; 160(4):476-477. PubMed ID: 38416455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of acrodermatitis continua of Hallopeau successfully treated with guselkumab.
    Buononato D; Licata G; Gambardella A; De Rosa A; Calabrese G; Argenziano G
    Dermatol Ther; 2022 Jul; 35(7):e15514. PubMed ID: 35420733
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful therapy of acrodermatitis continua of Hallopeau with IL-23 blockers -two new cases.
    Langer N; Wilsmann-Theis D; Kromer C; Mohr J; Mössner R
    J Dtsch Dermatol Ges; 2021 Oct; 19(10):1504-1507. PubMed ID: 34581001
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab.
    Yamamoto H; Kamiya K; Okada H; Maekawa T; Komine M; Ohtsuki M
    Int J Dermatol; 2023 Feb; 62(2):269-270. PubMed ID: 35187654
    [No Abstract]   [Full Text] [Related]  

  • 6. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Impetigo herpetiformis; acrodermatitis continua of Hallopeau and pustular psoriasis; etiology and pathogenesis and differential diagnosis].
    GRANELLI U
    Minerva Dermatol; 1956 Apr; 31(4):120-6. PubMed ID: 13348185
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of acrodermatitis continua of Hallopeau by TYK2 inhibitor with every other day.
    Kan Y; Uhara H
    J Dermatolog Treat; 2024 Dec; 35(1):2316239. PubMed ID: 38387442
    [No Abstract]   [Full Text] [Related]  

  • 9. Image Gallery: Pemphigus vulgaris mimicking acrodermatitis continua of Hallopeau.
    Chen Q; Du J; Jin J; Zhang J
    Br J Dermatol; 2020 Apr; 182(4):e115. PubMed ID: 31742663
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab treatment for acrodermatitis continua of Hallopeau: three cases refractory to IL-17 inhibition.
    Zhang Z; Wu X; Han C; Chen M; Liu Y
    J Dtsch Dermatol Ges; 2023 Jul; 21(7):785-787. PubMed ID: 37186059
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of acrodermatitis continua of Hallopeau with apremilast.
    Kurihara Y; Nakano K; Eto A; Furue M
    J Dermatol; 2019 Oct; 46(10):e370-e371. PubMed ID: 31131903
    [No Abstract]   [Full Text] [Related]  

  • 12. Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast.
    Lanna C; Cesaroni GM; Mazzilli S; Lozzi F; Palumbo V; Diluvio L; Bianchi L; Campione E
    Dermatol Ther; 2019 Jul; 32(4):e12946. PubMed ID: 31025500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apremilast as a new treatment option for Acrodermatitis continua of Hallopeau.
    Calleja Algarra A; Aragón Miguel R; Velasco Tamariz V; Prieto Barrios M; Andrés Lencina JJ; Vico Alonso C; Ortiz Romero PL; Rivera Díaz R
    Australas J Dermatol; 2019 Aug; 60(3):e237-e238. PubMed ID: 30623424
    [No Abstract]   [Full Text] [Related]  

  • 14. Acrodermatitis continua of Hallopeau in an elderly patient successfully and rapidly treated with risankizumab: a case report.
    Orsini D; Iacovelli P; Frascione P; Pacifico A
    J Dermatolog Treat; 2023 Dec; 34(1):2229468. PubMed ID: 37381703
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid and sustained response to apremilast in a patient with long-standing acrodermatitis continua of Hallopeau.
    Fusta-Novell X; Esquius M; Creus-Vila L
    Dermatol Online J; 2022 Dec; 28(6):. PubMed ID: 36809102
    [No Abstract]   [Full Text] [Related]  

  • 16. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review.
    Ruggiero A; Patruno C; Napolitano M; Megna M; Gisonni P; Cirillo T; Fabbrocini G
    Dermatol Ther; 2020 Nov; 33(6):e14046. PubMed ID: 32700773
    [No Abstract]   [Full Text] [Related]  

  • 18. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acrodermatitis continua, pustular psoriasis and impetigo herpetiformis].
    VAN SCHOUWEN M
    Ned Tijdschr Geneeskd; 1953 Jan; 97(2):79-85. PubMed ID: 13054802
    [No Abstract]   [Full Text] [Related]  

  • 20. Squamous cell carcinoma arising on acrodermatitis continua of Hallopeau: clinical and noninvasive skin imaging features.
    Cinotti E; Santi F; Perrot JL; Habougit C; Tognetti L; Rubegni P
    Int J Dermatol; 2021 Jun; 60(6):763-765. PubMed ID: 33241565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.